AC
AKJC
RKJMKM
SHKMPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
BioCrystbiocryst.com AKJCAC |
BioCryst is a commercial-stage biotechnology company developing first-in-class and best-in-class oral small-molecule and injectabl | Durham, North Carolina | 201-1000 | — |
KalVista Pharmaceuticalskalvista.com  BK JCKK |
KalVista Pharmaceuticals is a biotechnology company developing oral on-demand small molecule medicines for hereditary angioedema ( | Framingham, Massachusetts | 201-1000 | — |
Astria Therapeuticsastriatx.com |
Astria Therapeutics is a biotechnology company developing therapies for Hereditary Angioedema (HAE) and rare allergic and immunolo | Boston, Massachusetts | 51-200 | — |
Takedatakeda.com  GRYSTT |
Takeda is a global pharmaceutical company operating in more than 80 countries, with a 240-year legacy of improving healthcare worl | — | — | — |
CSL Behringcslbehring.com |
CSL Behring is a global biotherapeutics company that discovers, develops, and delivers innovative therapies for serious and rare d | King of Prussia, Pennsylvania | 1-10 | — |
Pharming Group N.V.pharming.com  LMJFGF |
Pharming Group N.V. is a global biopharmaceutical company headquartered in Leiden, The Netherlands, developing and commercializing | — | — | — |
Ionis Pharmaceuticalsionis.com  JEJP JR |
Ionis Pharmaceuticals is a biotechnology company that invents and delivers RNA- and DNA-targeted medicines for people living with | Carlsbad, California | 1001-5000 | — |
Pharvarispharvaris.com LZKR  TH |
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists as alternatives to i | Zug, Massachusetts | 51-200 | — |
Intelliatxintelliatx.com  JL AS RK |
Intellia Therapeutics is a clinical-stage biopharmaceutical company developing CRISPR-based gene editing therapies to treat severe | Cambridge, Massachusetts | 201-1000 | — |
Attune Pharmaceuticalsattunepharma.com |
Attune Pharmaceuticals is a private biotechnology company discovering and developing novel orally-administered small-molecule ther | New York, New York | 1-10 | — |
Adverum Biotechnologiesadverum.com  CL DV VB |
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage biotechnology company developing Ixo-vec, an investigational AAV gene t | Redwood City, California | 51-200 | — |
Sobisobi.com JM  AONN |
Sobi (Swedish Orphan Biovitrum AB) is a biopharmaceutical company that funds and organizes Partnering4PNH, a global multistakehold | — | — | — |
Dyaxdyax.com BL  A(CD |
Dyax is a biotechnology research company based in Burlington, Massachusetts, founded in 1989 with 51-200 employees, which was acqu | Burlington, Massachusetts | 51-200 | — |
Ansun Biopharmaansunbiopharma.com |
Ansun Biopharma is a late-stage clinical development company based in San Diego, California, developing first-in-class biologics t | San Diego, California | 11-50 | — |
Aqualung Therapeuticsaqualungtherapeutics.com |
Aqualung Therapeutics is a biotechnology company developing multi-pronged strategies to address severe lung inflammation, targetin | Tucson, Arizona | 1-10 | — |
Catalyst Biosciencescatbio.com |
Catalyst Bio is a research and clinical development biopharmaceutical company focused on rare disorders of the complement and coag | South San Francisco, California | 51-200 | — |
Catabasis Pharmaceuticalscatabasis.com |
Astria Therapeutics is a biopharmaceutical company developing therapies for Hereditary Angioedema (HAE) and other rare allergic an | Boston, Massachusetts | 51-200 | — |
Brii Biosciencesbriibio.com |
Brii Biosciences Limited (Brii Bio, stock code 2137.HK) is a biotechnology company developing therapies for patients with high unm | Durham, North Carolina | 51-200 | — |
AnaptysBioanaptysbio.com |
AnaptysBio is a royalty management company that exclusively manages the financial collaborations for Jemperli with GSK and imsidol | San Diego, California | 51-200 | — |
CRISPR Therapeuticscrisprtx.com |
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever appr | Boston, Massachusetts | 201-1000 | — |
REGENXBIOregenxbio.com |
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene | Rockville, Maryland | 201-1000 | — |
Biogenbiogen.com |
Biogen is a biotechnology company founded in 1978 and headquartered in Cambridge, Massachusetts, that develops first-in-class medi | Cambridge, Massachusetts | 5000+ | — |
Pfizerpfizer.com |
Pfizer is one of the world's premier biopharmaceutical companies, developing and manufacturing medicines and vaccines across inter | New York, New York | 5000+ | — |
4Dmt4dmt.com |
— | — | — | |
AbbVieabbvie.com |
AbbVie is a global biopharmaceutical company that discovers and delivers innovative medicines and solutions for complex health iss | North Chicago, Illinois | 5000+ | — |
Editas Medicineeditasmedicine.com |
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipel | Cambridge, Massachusetts | 51-200 | — |
Novartisnovartis.com |
Novartis is an innovative medicines company that discovers and commercializes medicines across cardiovascular, renal and metabolic | — | — | — |
Alnylamalnylam.com |
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNAi therapeutics, developing medicines that silence | Cambridge, Massachusetts | 1001-5000 | — |
uniQureuniqure.com |
uniQure is a gene therapy company with a modular, validated technology platform that advances a pipeline of proprietary and partne | Amsterdam, 1105BP | 201-1000 | — |
Beam Therapeuticsbeamtx.com |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
| Run live for more | ||||
BioCryst is a commercial-stage biotechnology company developing first-in-class and best-in-class oral small-molecule and injectable protein therapeutics for patients with hereditary angioedema (HAE) and other rare diseases, using a structure-guided drug design approach.
Companies like BioCryst include KalVista Pharmaceuticals, Astria Therapeutics, Takeda, CSL Behring, Pharming Group N.V.. See the full list of 24 competitors and alternatives above.
BioCryst has approximately 201-1000 employees and is in the Biotechnology Research industry.
BioCryst is headquartered in Durham, North Carolina.
BioCryst operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at BioCryst are listed above, including leaders across executive, finance, sales and operations.